Spectral Medical Inc
EDT
Company Profile
Business description
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Contact
135 The West Mall
Unit 2, Finance
TorontoONM9C 1C2
CANT: +1 416 626-3233
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
29
Stocks News & Analysis
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,080.70 | 39.80 | -0.44% |
| CAC 40 | 7,765.13 | 30.29 | 0.39% |
| DAX 40 | 23,736.60 | 70.53 | -0.30% |
| Dow JONES (US) | 45,514.95 | 106.34 | -0.23% |
| FTSE 100 | 9,251.15 | 29.71 | 0.32% |
| HKSE | 25,938.13 | 304.22 | 1.19% |
| NASDAQ | 21,798.70 | 91.01 | 0.42% |
| Nikkei 225 | 43,459.29 | 184.52 | -0.42% |
| NZX 50 Index | 13,253.73 | 27.41 | -0.21% |
| S&P 500 | 6,495.15 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,803.50 | 37.40 | -0.42% |
| SSE Composite Index | 3,807.29 | 19.55 | -0.51% |